Journal of Tuberculosis and Therapeutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Review Article   
  • J Tuberc Ther 2018, Vol 3(3): 119

Novel and Emerging Approach in the Diagnosis and Prognosis of Tuberculosis by Using Biomarkers

Sangeeta Meena, Shivangi and Laxman S. Meena*
CSIR-Institute of Genomics and Integrative Biology, Delhi, India
*Corresponding Author : Laxman S. Meena, CSIR-Institute of Genomics and Integrative Biology, Mall Road, Delhi, P.O. Box 110007, India, Tel: 011-27002200 Exn. 011-27667471, Email: laxmansm72@yahoo.com

Received Date: Jul 03, 2018 / Accepted Date: Jul 19, 2018 / Published Date: Jul 26, 2018

Keywords: Tuberculosis; Biomarkers; H37Rv pathogenesis; Mycobacterial genetics

Citation: Meena S, Shivangi, Meena LS (2018) Novel and Emerging Approach in the Diagnosis and Prognosis of Tuberculosis by Using Biomarkers. J Tuberc Ther 3: 119.

Copyright: © 2018 Meena LS, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top